Vitamin B3 Supplement Reduces Skin Cancer Risk
“`html
Nicotinamide Supplementation May Reduce Skin Cancer Risk, Study Finds
Table of Contents
Published October 12, 2025, at 07:34:17 AM PDT
This article provides an overview of recent research into the potential preventative effects of nicotinamide supplementation on skin cancer, offering context, analysis, and practical takeaways.
The Promise of Nicotinamide for Skin Cancer Prevention
Nicotinamide, a cost-effective and widely accessible form of vitamin B3, is emerging as a potential ally in the fight against skin cancer. Researchers have observed that this supplement enhances the skin’s natural repair mechanisms following ultraviolet (UV) damage, reduces inflammation, and strengthens the immune system’s ability to identify and eliminate abnormal cells.
A recent study, published in May 2024 in the Journal of the National Cancer Institute,provides compelling evidence for these benefits. The study compared over 12,000 individuals who began taking nicotinamide at a dosage of 500mg twice daily for at least one month with a control group of more than 21,000 who did not supplement.
Study Findings: A 14% reduction in Overall Risk
The results indicated that participants taking nicotinamide experienced a 14% reduction in the risk of developing any new skin cancer. However, the protective effect was most significant when supplementation was initiated soon after a first diagnosis of skin cancer, leading to a remarkable 54% decrease in the risk of subsequent cancers.
This highlights the importance of timing; the benefit diminished when supplementation began after multiple recurrences. The positive effects were observed across both basal cell carcinoma and squamous cell carcinoma, with a particularly pronounced impact on squamous cell carcinoma, a type known for its potentially aggressive behavior and increased risk of complications.
understanding the Types of Skin Cancer
Skin cancer is the most common form of cancer in the United States, according to the National cancer institute. Ther are several types, with basal cell carcinoma and squamous cell carcinoma being the most prevalent. Melanoma is less common but more dangerous.
| Skin Cancer Type | Prevalence (US) | Aggressiveness | Metastasis Risk |
|---|---|---|---|
| Basal Cell Carcinoma | ~80% of all skin cancers | Slow-growing | Low |
| Squamous Cell Carcinoma | ~20% of all skin cancers | Variable, can be aggressive | Moderate |
| Melanoma | ~1% of all skin cancers | Highly aggressive | High |